The following table reconciles MedCath Corporation's diluted (loss) earnings per share from continuing operations, net of taxes attributable to MedCath Corporation's common stockholders as derived directly from MedCath's consolidated financial statements to Adjusted diluted earnings per share from continuing operations (inclusive of the effect of dilutive shares) for the three and six months ended March 31, 2011 and 2010.
Three Months Ended March 31,
Six Months Ended March 31,
Diluted (loss) earnings per share
Gain on sale of unconsolidated affiliates
Professional fees for strategic options process
Sales tax refunds
Impairment of long-lived assets
Loss on note receivable
Share-based compensation expense
Adjusted diluted earnings per share
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All